NCT06678373View on ClinicalTrials.gov

Monitoring JE Antibody Levels in Healthy Populations and Immunization Strategy in Low-Prevalence Areas

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

November 14, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Japanese Encephalitis
Interventions
BIOLOGICAL

Liaoning Chengda Inactivated Japanese Encephalitis Vaccine

The patient needs to receive 1 dose of inactivated Japanese encephalitis vaccine.

BIOLOGICAL

Liaoning Chengda Inactivated Japanese Encephalitis Vaccine

The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 28 days.

BIOLOGICAL

Liaoning Chengda Inactivated Japanese Encephalitis Vaccine

The patient needs to receive 2 doses of inactivated Japanese encephalitis vaccine, with an interval of 7 days.

Trial Locations (1)

110100

Liaoning Provincial Center for Disease Control and Prevention, Shenyang

All Listed Sponsors
lead

Liaoning Chengda Biotechnology CO., LTD

INDUSTRY